Dosing: Altered kidney function
No kidney-specific text is available from the US label for this generic yet. Check the Philippine package insert in the products table.
Kidney-specific guidance from renalcarematters.com: in preparation.
Dosage forms
Philippines
- Per solution for injection: 2 mg/20 mg/1 mL
Registered products in the Philippines
1 product registered with the Food and Drug Administration (FDA) Philippines list Glycine + Glycyrrhizic acid + L-cysteine as the generic name. Registration status changes; confirm a product's current status on the FDA portal before relying on it.
| Package insert | |||||||
|---|---|---|---|---|---|---|---|
Minophagen CGlycyrrhizic Acid + Glycine + L-Cysteine Hydrochloride | 2mg/20mg/1mL per Solution for Injection (IV)20mL Low Density Polyethylene (LDPE) ampoule individually encased in an oxygen barrier film bag and 10 ampoules are packed in a pillow bag (Box of 10's) | Rx | Minophagen Pharmaceutical Co.. Ltd.Japan | Zuellig Pharma CorporationImporter: HI-EISAI PHARMACEUTICAL INC. | DR-XY45821 | Mar 28, 2032 |
Source: FDA Philippines product registration database. "Valid until" is the registration validity date listed by the FDA; a past date may mean a renewal is pending. Package insert links point to files published by the FDA.
Formulary and pricing (Philippines)
Check availability
Prices and stock vary by branch; renalcarematters.com does not sell medicines or receive payment from pharmacies.
References
- Food and Drug Administration Philippines. Verification portal (product registrations). https://verification.fda.gov.ph
This page shows official label and registry text only; no renalcarematters.com clinical summary has been approved for it yet.
Last updated: .